Honouring excellence: 2024 CDE of the Year Award recipients announced

23 August 2024—ADEA is proud to announce the recipients of the 2024 CDE of the Year Awards, recognising outstanding contributions to diabetes education and care across Australia.

These prestigious awards were announced at the Australasian Diabetes Congress on 23 August, celebrating the dedication and expertise of CDEs who have gone above and beyond to support people living with diabetes, their families, and communities.

Jan Baldwin National CDE of the Year

Julie Kha has been awarded the Jan Baldwin National CDE of the Year for her exceptional contributions to diabetes education at both state and national levels.

Her commitment to advancing diabetes care and her impact on the community exemplify the highest standards of the profession.

ADEA is honoured to recognise her with this prestigious award.

State and Territory CDE of the Year Award Recipients

The ADEA is also pleased to recognise the exceptional work of CDEs across the states and territories.

These CDEs have made significant contributions within their local communities, ensuring that people living with diabetes receive the highest quality of care and support.

New Categories

This year, ADEA is pleased to announce the inclusion of three new categories to the CDE of the Year 2024 awards:

The CDE of the Year Awards are an annual highlight, showcasing the excellence and leadership of the CDE profession.

The 2024 recipients have set a high standard of practice and have significantly contributed to enhancing diabetes education and care in Australia.

In the coming weeks, ADEA will feature profiles of each recipient, highlighting their unique contributions and stories.

The awards are run by ADEA with financial support from global research-based pharmaceutical company Eli Lilly.

Honouring excellence: 2024 CDE of the Year Award recipients announced

23 August 2024—ADEA is proud to announce the recipients of the 2024 CDE of the Year Awards, recognising outstanding contributions to diabetes education and care across Australia.

These prestigious awards were announced at the Australasian Diabetes Congress on 23 August, celebrating the dedication and expertise of CDEs who have gone above and beyond to support people living with diabetes, their families, and communities.

Jan Baldwin National CDE of the Year

Julie Kha has been awarded the Jan Baldwin National CDE of the Year for her exceptional contributions to diabetes education at both state and national levels.

Her commitment to advancing diabetes care and her impact on the community exemplify the highest standards of the profession.

ADEA is honoured to recognise her with this prestigious award.

State and Territory CDE of the Year Award Recipients

The ADEA is also pleased to recognise the exceptional work of CDEs across the states and territories.

These CDEs have made significant contributions within their local communities, ensuring that people living with diabetes receive the highest quality of care and support.

  • Tasmania: Margaret Arvier
  • Queensland: Susan Carbone and Louise Moran
  • Australian Capital Territory: Isabel Reeves
  • Victoria: Claire Gatto
  • Western Australia: Valerie Merle Taylor
  • Northern Territory: Deborah Aberasturi
  • South Australia: Julie Kha

New Categories

This year, ADEA is pleased to announce the inclusion of three new categories to the CDE of the Year 2024 awards:

  • Early Career CDE of the Year: Trent Lyon
  • Aboriginal or Torres Strait Islander CDE of the Year: Jade Kelly
  • People’s Choice CDE of the Year: Swarnamalie Indushyama Jayakody Arachchige

The CDE of the Year Awards are an annual highlight, showcasing the excellence and leadership of the CDE profession.

The 2024 recipients have set a high standard of practice and have significantly contributed to enhancing diabetes education and care in Australia.

In the coming weeks, ADEA will feature profiles of each recipient, highlighting their unique contributions and stories.

The awards are run by ADEA with financial support from global research-based pharmaceutical company Eli Lilly.